Real-world safety among patients with locally advanced or metastatic urothelial cancer (la/mUC) treated with first-line (1L) systemic regimens: Results from the ELEVATE UC-I study.

Authors: Amanda Nizam, Chiemeka Ike, Valerie Morris, Carroline Lobo, Seyed Hamidreza Mahmoudpour, Mairead Kearney, Jason Hoffman, Ning A. Rosenthal, Isabel Gomez, Chendi Cui

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e16554

Source: Full article

---

Abstract

e16554